CombiMatrix to Obtain $10.5M in Stock Placement

genomeweb
360dx

CombiMatrix to Obtain $10.5M in Stock Placement

Sep 16, 2005

NEW YORK, Sept. 16 (GenomeWeb News) - CombiMatrix will receive $10.5 million from a registered direct stock offering by its parent company, Acacia Research, the company said today.

To read the full story....

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Genetic Signatures Gets CE Mark for 'Superbugs' Kit
New Products Posted to GenomeWeb: Thermo Fisher Scientific, Bio-Techne, Mission Bio, More
Taconic Biosciences Licenses Easi-CRISPR Tech
Altona Gets CE Mark for Diagnostics Workflow
Chemotherapy Resistance Pathway for AML Identified in CRISPRa Screen
Chemotherapy Resistance Pathway for AML Identified in CRISPRa Screen

The Scan

Drive Away the Flies

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

Fewer Transfusions Needed

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

This Week in Nature

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Alteration Here and There to Win

Futurism writes that gene doping could be the next generation of cheating in sports.

Main menu